Scienture Holdings Inc (SCNX) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Scienture Holdings Inc   (NASDAQ: SCNX)
 

Scienture Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Scienture Holdings Inc 's inventory turnover ratio, the ratio that measures Scienture Holdings Inc 's ability to manage its supply chain, sequentially decreased to 0.56 in the first quarter 2026, but it does not raise any concerns as Scienture Holdings Inc continue to execute well, and the inventory turnover ratio remains above the average. Scienture Holdings Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 652 days, from 410 days, in the Dec 31 2025 quarter.

Within Healthcare sector Scienture Holdings Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2026 compared to previous quarter at no. .

SCNX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Scienture Holdings Inc Market Share?

What is Inventory Turnover Ratio?




SCNX Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth - - 2874.64 % - -
Y / Y Cost of Sales Growth -74.18 % 49.45 % -74.7 % - -
Inventory Turnover Ratio (TTM) 0.56 0.89 1.28 - -
SCNX's Total Ranking # # # # #
Average inventory processing period 646 408 284 - -
Seq. Inventory Growth -1.16 % -9 % - - -
Seq. Cost of Sales Growth -96.7 % 386.83 % - - -80.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Scienture Holdings Inc 's Inventories $ 0 Millions Visit SCNX's Balance sheet
Scienture Holdings Inc 's Cost of Revenues TTM $ 0 Millions Visit SCNX's Income Statement
What are SCNX's Sales? Visit SCNX's Sales by Segment

Other Inventory Turnover Ratios
Scienture Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SCNX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SCNX's Competitors
Inventory Turnover Ratio for SCNX's Suppliers
Inventory Turnover Ratio for SCNX's Customers

You may also want to know
SCNX's Sales Growth Rates SCNX's Pe Price to earnings ratio SCNX's Receivables Turnover Ratio SCNX's Stock Quote
SCNX's Net Income Growth Rates SCNX's Ps Price to Sales ratio SCNX's Sales per Employee SCNX's Asset Turnover Ratio
SCNX's Net Margin SCNX's Pb Price to Book ratio SCNX's Financial Strength Ratios SCNX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Insmed Inc  1.21 $ 149.080  Millions$ 123  Millions
Si bone inc   1.21 $ 42.000  Millions$ 35  Millions
Assertio Holdings inc   1.16 $ 30.308  Millions$ 26  Millions
Beone Medicines Ltd   1.15 $ 670.000  Millions$ 581  Millions
Biogen Inc   1.13 $ 2,435.900  Millions$ 2,150  Millions
Bridgebio Pharma Inc   1.10 $ 28.262  Millions$ 26  Millions
60 Degrees Pharmaceuticals Inc   1.10 $ 0.794  Millions$ 1  Millions
Penumbra Inc  1.10 $ 474.318  Millions$ 433  Millions
Keenova Therapeutics Plc  1.09 $ 815.400  Millions$ 749  Millions
Zoetis Inc   1.09 $ 2,685.000  Millions$ 2,471  Millions
Treace Medical Concepts Inc   1.08 $ 42.052  Millions$ 39  Millions
Corcept Therapeutics Inc  1.07 $ 13.457  Millions$ 13  Millions
Zimmer Biomet Holdings Inc   1.06 $ 2,520.100  Millions$ 2,368  Millions
Acadia Pharmaceuticals Inc   1.06 $ 93.397  Millions$ 88  Millions
Vertex Pharmaceuticals Inc  1.02 $ 1,681.100  Millions$ 1,645  Millions
Sensus Healthcare Inc   1.02 $ 14.403  Millions$ 14  Millions
Blue Water Vaccines Inc  1.01 $ 0.150  Millions$ 0  Millions
Pacira Biosciences inc   1.00 $ 151.856  Millions$ 152  Millions
Profound Medical Corp   1.00 $ 5.442  Millions$ 5  Millions
Hyperfine Inc   0.99 $ 6.000  Millions$ 6  Millions
Petvivo Holdings Inc   0.99 $ 0.486  Millions$ 0  Millions
Ionis Pharmaceuticals Inc   0.97 $ 8.597  Millions$ 9  Millions
Rhythm Pharmaceuticals Inc   0.96 $ 23.001  Millions$ 24  Millions
Eli Lilly And Company  0.96 $ 12,404.800  Millions$ 12,867  Millions
Rxsight Inc   0.96 $ 29.000  Millions$ 30  Millions
Adma Biologics Inc   0.96 $ 195.347  Millions$ 204  Millions
Protalix Biotherapeutics inc   0.93 $ 22.940  Millions$ 25  Millions
Alkermes Plc   0.91 $ 208.838  Millions$ 229  Millions
Emergent Biosolutions Inc   0.91 $ 309.700  Millions$ 341  Millions
Inspire Medical Systems inc   0.90 $ 130.000  Millions$ 144  Millions

Date modified: 2026-06-22T14:32:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.